U.S. markets open in 8 hours 41 minutes
  • S&P Futures

    4,241.50
    +10.00 (+0.24%)
     
  • Dow Futures

    33,852.00
    +93.00 (+0.28%)
     
  • Nasdaq Futures

    14,301.00
    +38.00 (+0.27%)
     
  • Russell 2000 Futures

    2,308.30
    +8.00 (+0.35%)
     
  • Crude Oil

    73.14
    +0.06 (+0.08%)
     
  • Gold

    1,774.10
    -9.30 (-0.52%)
     
  • Silver

    25.91
    -0.21 (-0.79%)
     
  • EUR/USD

    1.1929
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.32
    -0.34 (-2.04%)
     
  • GBP/USD

    1.3962
    -0.0001 (-0.01%)
     
  • USD/JPY

    110.9650
    +0.0030 (+0.00%)
     
  • BTC-USD

    32,586.06
    -1,345.80 (-3.97%)
     
  • CMC Crypto 200

    786.21
    -23.99 (-2.96%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,874.05
    -0.84 (-0.00%)
     

Top Ranked Momentum Stocks to Buy for May 26th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 26th:

Kala Pharmaceuticals, Inc. (KALA): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.

Kala Pharmaceuticals, Inc. Price and Consensus

Kala Pharmaceuticals, Inc. Price and Consensus
Kala Pharmaceuticals, Inc. Price and Consensus

Kala Pharmaceuticals, Inc. price-consensus-chart | Kala Pharmaceuticals, Inc. Quote

Kala Pharmaceuticals’ shares gained 39.4% over the last one month above the S&P 500’s gain of 6%. The company possesses a Momentum Score of B.

Kala Pharmaceuticals, Inc. Price

Kala Pharmaceuticals, Inc. Price
Kala Pharmaceuticals, Inc. Price

Kala Pharmaceuticals, Inc. price | Kala Pharmaceuticals, Inc. Quote

Kopin Corporation (KOPN): This developer of components, subassemblies, head-worn and hand-held systems has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.

Kopin Corporation Price and Consensus

Kopin Corporation Price and Consensus
Kopin Corporation Price and Consensus

Kopin Corporation price-consensus-chart | Kopin Corporation Quote

Kopin’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of B.

Kopin Corporation Price

Kopin Corporation Price
Kopin Corporation Price

Kopin Corporation price | Kopin Corporation Quote

Minerva Neurosciences, Inc. (NERV): This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.

Minerva Neurosciences, Inc Price and Consensus

Minerva Neurosciences, Inc Price and Consensus
Minerva Neurosciences, Inc Price and Consensus

Minerva Neurosciences, Inc price-consensus-chart | Minerva Neurosciences, Inc Quote

Minerva Neurosciences’ shares gained 74.2% over the last one month. The company possesses a Momentum Score of B.

Minerva Neurosciences, Inc Price

Minerva Neurosciences, Inc Price
Minerva Neurosciences, Inc Price

Minerva Neurosciences, Inc price | Minerva Neurosciences, Inc Quote

Rayonier Advanced Materials Inc. (RYAM): This producer of natural gas and crude oil has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days

Rayonier Advanced Materials Inc. Price and Consensus

Rayonier Advanced Materials Inc. Price and Consensus
Rayonier Advanced Materials Inc. Price and Consensus

Rayonier Advanced Materials Inc. price-consensus-chart | Rayonier Advanced Materials Inc. Quote

Rayonier Advanced Materials’ shares gained more than 76.2% over the last one month. The company possesses a Momentum Score of B.

Rayonier Advanced Materials Inc. Price

Rayonier Advanced Materials Inc. Price
Rayonier Advanced Materials Inc. Price

Rayonier Advanced Materials Inc. price | Rayonier Advanced Materials Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Rayonier Advanced Materials Inc. (RYAM) : Free Stock Analysis Report
 
Minerva Neurosciences, Inc (NERV) : Free Stock Analysis Report
 
Kopin Corporation (KOPN) : Free Stock Analysis Report
 
Kala Pharmaceuticals, Inc. (KALA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research